BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• MethylGene Presents Favorable Clinical Data for Mocetinostat at the 52nd American Society of Hematology Annual Meeting

  December 6, 2010

   · 

  6 min read
• Business

  Theratechnologies Inc. Announces a Distribution and Licensing Agreement for EGRIFTA(TM) in Latin America, Africa and the Middle East With Sanofi-Aventis (France)

  December 6, 2010

   · 

  5 min read
• Business

  Asuragen, Inc. Announces Collaboration on the Development of BCR-ABL1 RNA IS Calibrators and Laboratory Software Reporting Tool at American Society of Hematology

  December 6, 2010

   · 

  1 min read
• Drug Development

  Immunomedics, Inc.'s Results From Phase II Trial of Epratuzumab and Rituximab as Initial Treatment for Follicular Lymphoma Reported in an Oral Presentation at American Society of Hematology

  December 6, 2010

   · 

  1 min read
• Drug Development

  Achillion Pharmaceuticals, Inc. to Present Data From Studies of ACH-1625 in Hepatitis C at Asian Pacific Liver Conference

  December 6, 2010

   · 

  1 min read
• Drug Development

  Cyclacel Pharmaceuticals, Inc. Reports Phase 2 Survival Data With Sapacitabine in Myelodysplastic Syndromes at 2010 American Society of Hematology Annual Meeting

  December 6, 2010

   · 

  1 min read
• Genetown

  Acetylon Pharmaceuticals Announces Publication of Preclinical Safety and Efficacy Results for Lead Drug Candidate ACY-1215 in Multiple Myeloma

  December 6, 2010

   · 

  1 min read
• Drug Development

  Long-Term Follow-Up Data from Phase 2 Study Show Micromet’s Blinatumomab Produces Durable Remissions in Patients with Acute Lymphoblastic Leukemia

  December 6, 2010

   · 

  1 min read
• Novo Nordisk A/S - Share Repurchase Programme

  December 6, 2010

   · 

  1 min read
• Drug Development

  UCB Group: Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) C-V Effectively Reduced Partial-Onset Seizure Frequency and Improved Health-related Quality of Life

  December 6, 2010

   · 

  14 min read